Shawn Olsson's most recent trade in LENZ Therapeutics Inc. was a trade of 1,400 Common Stock done at an average price of $2.1 . Disclosure was reported to the exchange on April 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| LENZ Therapeutics Inc. | Shawn Olsson | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.08 per share. | 09 Apr 2025 | 1,400 | 4,733 | - | 2.1 | 2,912 | Common Stock |
| LENZ Therapeutics Inc. | Shawn Olsson | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2025 | 1,400 | 63,241 | - | - | Stock Option (right to buy) | |
| LENZ Therapeutics Inc. | Shawn Olsson | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2025 | 80,100 | 80,100 | - | - | Stock Option (right to buy) | |
| LENZ Therapeutics Inc. | Shawn Olsson | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2024 | 3,333 | 64,641 | - | - | Stock Option (right to buy) | |
| LENZ Therapeutics Inc. | Shawn Olsson | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.08 per share. | 16 Dec 2024 | 3,333 | 3,333 | - | 2.1 | 6,933 | Common Stock |
| LENZ Therapeutics Inc. | Shawn Olsson | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 105,000 | 105,000 | - | - | Stock Option (right to buy) | |
| LENZ Therapeutics Inc. | Shawn Olsson | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 67,974 | 67,974 | - | - | Stock Option (right to buy) | |
| LENZ Therapeutics Inc. | Shawn Olsson | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 50,915 | 50,915 | - | - | Stock Option (right to buy) | |
| LENZ Therapeutics Inc. | Shawn Olsson | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 30,466 | 30,466 | - | - | Stock Option (right to buy) |